
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
An updated insight into the molecular pathogenesis, secondary complications and potential therapeutics of COVID-19 pandemic
Sumit Jamwal, Akash Gautam, John D. Elsworth, et al.
Life Sciences (2020) Vol. 257, pp. 118105-118105
Open Access | Times Cited: 68
Sumit Jamwal, Akash Gautam, John D. Elsworth, et al.
Life Sciences (2020) Vol. 257, pp. 118105-118105
Open Access | Times Cited: 68
Showing 1-25 of 68 citing articles:
SARS-CoV-2 and nervous system: From pathogenesis to clinical manifestation
Kiandokht Keyhanian, Raffaella Pizzolato Umeton, Babak Mohit, et al.
Journal of Neuroimmunology (2020) Vol. 350, pp. 577436-577436
Open Access | Times Cited: 140
Kiandokht Keyhanian, Raffaella Pizzolato Umeton, Babak Mohit, et al.
Journal of Neuroimmunology (2020) Vol. 350, pp. 577436-577436
Open Access | Times Cited: 140
The impact of the COVID-19 pandemic on lifestyle behaviors in children and adolescents: an international overview
Serena Scapaticci, Costanza Neri, Gian Luigi Marseglia, et al.
The Italian Journal of Pediatrics/Italian journal of pediatrics (2022) Vol. 48, Iss. 1
Open Access | Times Cited: 75
Serena Scapaticci, Costanza Neri, Gian Luigi Marseglia, et al.
The Italian Journal of Pediatrics/Italian journal of pediatrics (2022) Vol. 48, Iss. 1
Open Access | Times Cited: 75
<p>N-Acetylcysteine to Combat COVID-19: An Evidence Review</p>
Zhongcheng Shi, Carlos A. Puyo
Therapeutics and Clinical Risk Management (2020) Vol. Volume 16, pp. 1047-1055
Open Access | Times Cited: 115
Zhongcheng Shi, Carlos A. Puyo
Therapeutics and Clinical Risk Management (2020) Vol. Volume 16, pp. 1047-1055
Open Access | Times Cited: 115
A scope of mobile health solutions in COVID-19 pandemics
Afsoon Asadzadeh, Leila R Kalankesh
Informatics in Medicine Unlocked (2021) Vol. 23, pp. 100558-100558
Open Access | Times Cited: 83
Afsoon Asadzadeh, Leila R Kalankesh
Informatics in Medicine Unlocked (2021) Vol. 23, pp. 100558-100558
Open Access | Times Cited: 83
COVID‑19 and ischemic stroke: Mechanisms of hypercoagulability (Review)
Shuoqi Zhang, Jinming Zhang, Chunxu Wang, et al.
International Journal of Molecular Medicine (2021) Vol. 47, Iss. 3
Open Access | Times Cited: 80
Shuoqi Zhang, Jinming Zhang, Chunxu Wang, et al.
International Journal of Molecular Medicine (2021) Vol. 47, Iss. 3
Open Access | Times Cited: 80
Identification of alkaloids from Justicia adhatoda as potent SARS CoV-2 main protease inhibitors: An in silico perspective
Rajesh Ghosh, Ayon Chakraborty, Ashis Biswas, et al.
Journal of Molecular Structure (2020) Vol. 1229, pp. 129489-129489
Open Access | Times Cited: 72
Rajesh Ghosh, Ayon Chakraborty, Ashis Biswas, et al.
Journal of Molecular Structure (2020) Vol. 1229, pp. 129489-129489
Open Access | Times Cited: 72
Internet-of-nano-things (IoNT) driven intelligent face masks to combat airborne health hazard
Vishal Chaudhary, Akash Gautam, Poonam Silotia, et al.
Materials Today (2022) Vol. 60, pp. 201-226
Open Access | Times Cited: 65
Vishal Chaudhary, Akash Gautam, Poonam Silotia, et al.
Materials Today (2022) Vol. 60, pp. 201-226
Open Access | Times Cited: 65
Age-Related Risk Factors and Complications of Patients With COVID-19: A Population-Based Retrospective Study
Han Zhang, Yingying Wu, Yuqing He, et al.
Frontiers in Medicine (2022) Vol. 8
Open Access | Times Cited: 64
Han Zhang, Yingying Wu, Yuqing He, et al.
Frontiers in Medicine (2022) Vol. 8
Open Access | Times Cited: 64
A bibliometric analysis of autophagy in lung diseases from 2012 to 2021
Feihong Lin, Yong Chen, Wei Mo, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 29
Feihong Lin, Yong Chen, Wei Mo, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 29
Neurological complications after COVID-19: A narrative review
Ghazale Molaverdi, Zahra Kamal, Mahshid Safavi, et al.
eNeurologicalSci (2023) Vol. 33, pp. 100485-100485
Open Access | Times Cited: 17
Ghazale Molaverdi, Zahra Kamal, Mahshid Safavi, et al.
eNeurologicalSci (2023) Vol. 33, pp. 100485-100485
Open Access | Times Cited: 17
Uncaria tomentosa(cat’s claw): a promising herbal medicine against SARS-CoV-2/ACE-2 junction and SARS-CoV-2 spike protein based on molecular modeling
A.F. Yepes, Oscar Herrera-Calderón, Jorge Quintero‐Saumeth
Journal of Biomolecular Structure and Dynamics (2020) Vol. 40, Iss. 5, pp. 2227-2243
Open Access | Times Cited: 40
A.F. Yepes, Oscar Herrera-Calderón, Jorge Quintero‐Saumeth
Journal of Biomolecular Structure and Dynamics (2020) Vol. 40, Iss. 5, pp. 2227-2243
Open Access | Times Cited: 40
A review on function and side effects of systemic corticosteroids used in high-grade COVID-19 to prevent cytokine storms.
Mohammad Amin Langarizadeh, Marziye Ranjbar Tavakoli, Ardavan Abiri, et al.
EXCLI journal (2021) Vol. 20, pp. 339-365
Closed Access | Times Cited: 38
Mohammad Amin Langarizadeh, Marziye Ranjbar Tavakoli, Ardavan Abiri, et al.
EXCLI journal (2021) Vol. 20, pp. 339-365
Closed Access | Times Cited: 38
CAR-NK Cells Effectively Target SARS-CoV-2-Spike-Expressing Cell Lines In Vitro
Minh Tuyet, Saiaditya Badeti, Chih-Hsiung Chen, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 37
Minh Tuyet, Saiaditya Badeti, Chih-Hsiung Chen, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 37
The effects of novel coronavirus (SARS-CoV-2) infection on cardiovascular diseases and cardiopulmonary injuries
Li Ni, Linwen Zhu, Lebo Sun, et al.
Stem Cell Research (2021) Vol. 51, pp. 102168-102168
Open Access | Times Cited: 33
Li Ni, Linwen Zhu, Lebo Sun, et al.
Stem Cell Research (2021) Vol. 51, pp. 102168-102168
Open Access | Times Cited: 33
Inhibition Potencies of Phytochemicals Derived from Sesame Against SARS-CoV-2 Main Protease: A Molecular Docking and Simulation Study
Anuj Kumar, Dwijesh Chandra Mishra, U. B. Angadi, et al.
Frontiers in Chemistry (2021) Vol. 9
Open Access | Times Cited: 33
Anuj Kumar, Dwijesh Chandra Mishra, U. B. Angadi, et al.
Frontiers in Chemistry (2021) Vol. 9
Open Access | Times Cited: 33
The polymorphism L412F in TLR3 inhibits autophagy and is a marker of severe COVID-19 in males
Susanna Croci, Mary Anna Venneri, Stefania Mantovani, et al.
Autophagy (2021) Vol. 18, Iss. 7, pp. 1662-1672
Open Access | Times Cited: 33
Susanna Croci, Mary Anna Venneri, Stefania Mantovani, et al.
Autophagy (2021) Vol. 18, Iss. 7, pp. 1662-1672
Open Access | Times Cited: 33
Autophagy Augmentation to Alleviate Immune Response Dysfunction, and Resolve Respiratory and COVID-19 Exacerbations
Garrett Pehote, Neeraj Vij
Cells (2020) Vol. 9, Iss. 9, pp. 1952-1952
Open Access | Times Cited: 35
Garrett Pehote, Neeraj Vij
Cells (2020) Vol. 9, Iss. 9, pp. 1952-1952
Open Access | Times Cited: 35
Computational drug repurposing strategy predicted peptide-based drugs that can potentially inhibit the interaction of SARS-CoV-2 spike protein with its target (humanACE2)
Samuel Egieyeh, Elizabeth Oyebola Egieyeh, Sarel F. Malan, et al.
PLoS ONE (2021) Vol. 16, Iss. 1, pp. e0245258-e0245258
Open Access | Times Cited: 28
Samuel Egieyeh, Elizabeth Oyebola Egieyeh, Sarel F. Malan, et al.
PLoS ONE (2021) Vol. 16, Iss. 1, pp. e0245258-e0245258
Open Access | Times Cited: 28
Gastrointestinal implications in COVID-19
Dushyant Singh Dahiya, Asim Kichloo, Michael Albosta, et al.
Journal of Investigative Medicine (2020) Vol. 68, Iss. 8, pp. 1397-1401
Closed Access | Times Cited: 32
Dushyant Singh Dahiya, Asim Kichloo, Michael Albosta, et al.
Journal of Investigative Medicine (2020) Vol. 68, Iss. 8, pp. 1397-1401
Closed Access | Times Cited: 32
Adverse drug reactions in SARS-CoV-2 hospitalised patients: a case-series with a focus on drug–drug interactions
Giada Crescioli, Valentina Brilli, Cecilia Lanzi, et al.
Internal and Emergency Medicine (2020) Vol. 16, Iss. 3, pp. 697-710
Open Access | Times Cited: 31
Giada Crescioli, Valentina Brilli, Cecilia Lanzi, et al.
Internal and Emergency Medicine (2020) Vol. 16, Iss. 3, pp. 697-710
Open Access | Times Cited: 31
Complication and Sequelae of COVID-19: What Should We Pay Attention to in the Post-Epidemic Era
Keda Yang, Guangfu Wen, Jinpeng Wang, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 25
Keda Yang, Guangfu Wen, Jinpeng Wang, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 25
Comprehensive role of SARS‐CoV‐2 spike glycoprotein in regulating host signaling pathway
Shuvomoy Banerjee, Xinyu Wang, Shujuan Du, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 9, pp. 4071-4087
Open Access | Times Cited: 15
Shuvomoy Banerjee, Xinyu Wang, Shujuan Du, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 9, pp. 4071-4087
Open Access | Times Cited: 15
Conceptual Framework for SARS-CoV-2–Related Lymphopenia
Ilnaz Rahimmanesh, Seyed Amin Kouhpayeh, Yadollah Azizi, et al.
Advanced Biomedical Research (2022) Vol. 11, Iss. 1, pp. 16-16
Open Access | Times Cited: 15
Ilnaz Rahimmanesh, Seyed Amin Kouhpayeh, Yadollah Azizi, et al.
Advanced Biomedical Research (2022) Vol. 11, Iss. 1, pp. 16-16
Open Access | Times Cited: 15
A robust innovative pipeline-based machine learning framework for predicting COVID-19 in Mexican patients
Rahman Farnoosh, Karlo Abnoosian
International Journal of Systems Assurance Engineering and Management (2024) Vol. 15, Iss. 7, pp. 3466-3484
Closed Access | Times Cited: 3
Rahman Farnoosh, Karlo Abnoosian
International Journal of Systems Assurance Engineering and Management (2024) Vol. 15, Iss. 7, pp. 3466-3484
Closed Access | Times Cited: 3
COVID‐19: An Overview of SARS‐CoV‐2 Variants—The Current Vaccines and Drug Development
Narjess Bostanghadiri, Pardis Ziaeefar, Morvarid Golrokh Mofrad, et al.
BioMed Research International (2023) Vol. 2023, Iss. 1
Open Access | Times Cited: 8
Narjess Bostanghadiri, Pardis Ziaeefar, Morvarid Golrokh Mofrad, et al.
BioMed Research International (2023) Vol. 2023, Iss. 1
Open Access | Times Cited: 8